{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:01Z","timestamp":1792728241451,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejphar.2009.03.025","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T08:38:59Z","timestamp":1237279139000},"page":"1-11","source":"Crossref","is-referenced-by-count":120,"title":["Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans"],"prefix":"10.1016","volume":"610","author":[{"given":"Wolfgang","family":"L\u00f6scher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.03.025_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3565(25)30638-5","article-title":"Anticonvulsant action of acute morphine administration in rats","volume":"198","author":"Adler","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2009.03.025_bib3","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.03.025_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(87)90428-8","article-title":"Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy","volume":"426","author":"Ault","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib6","first-page":"642","article-title":"Use of ketamine for activation of EEG and electrocorticographic records in patients with epilepsy","volume":"30","author":"Bacia","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-199819030-00002","article-title":"Adverse effects of opioid agonists and agonists\u2013antagonists in anaesthesia","volume":"19","author":"Bowdle","year":"1998","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2009.03.025_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1553-2712.2002.tb01609.x","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.ejphar.2009.03.025_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuropharm.2007.06.017","article-title":"Modafinil exerts a dose-dependent antiepileptic effect mediated by adrenergic alpha1 and histaminergic H1 receptors in mice","volume":"53","author":"Chen","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib10","series-title":"Kindling 4","first-page":"141","article-title":"Noradrenaline and kindling revisited","author":"Corcoran","year":"1990"},{"key":"10.1016\/j.ejphar.2009.03.025_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2002.tb00439.x","article-title":"Animal models of limbic epilepsies: what can they tell us?","volume":"12","author":"Coulter","year":"2002","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0028-3908(86)90169-3","article-title":"Effect of morphine and morphine-like analgesics on susceptibility to seizures in mice","volume":"25","author":"Czuczwar","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1528-1157.1986.tb03529.x","article-title":"Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice","volume":"27","author":"Czuczwar","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1157.1990.tb05382.x","article-title":"Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice","volume":"31","author":"Czuczwar","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0006-2952(96)00509-6","article-title":"Antidepressants and seizures: clinical anecdotes overshadow neuroscience","volume":"52","author":"Dailey","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00124509-200209000-00002","article-title":"Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal","volume":"18","author":"Datto","year":"2002","journal-title":"J. ECT"},{"key":"10.1016\/j.ejphar.2009.03.025_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-4274(95)80008-2","article-title":"Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem\/cilastatin and meropenem","volume":"76","author":"Day","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2009.03.025_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(99)00132-6","article-title":"Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA\/2 mice","volume":"371","author":"De Sarro","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00000542-199901000-00017","article-title":"Reducing myoclonus after etomidate","volume":"90","author":"Doenicke","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.spen.2005.12.004","article-title":"Childhood epilepsy, attention problems, and ADHD: review and practical considerations","volume":"12","author":"Dunn","year":"2005","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-8749.2003.tb00859.x","article-title":"ADHD and epilepsy in childhood","volume":"45","author":"Dunn","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.vascn.2007.03.006","article-title":"The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk","volume":"56","author":"D\u00fcrm\u00fcller","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2009.03.025_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/026988119200600213","article-title":"Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches","volume":"6","author":"Edwards","year":"1992","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2008.04.007","article-title":"Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine","volume":"55","author":"El Yacoubi","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib25","first-page":"341","article-title":"Interictal behavioral disturbances: a search for molecular substrates","volume":"9","author":"Engel","year":"1992","journal-title":"Epilepsy Res., Suppl."},{"key":"10.1016\/j.ejphar.2009.03.025_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.2042-7158.1989.tb06416.x","article-title":"Chronic but not acute antidepressant treatment increases pentetrazol-induced convulsions in mice","volume":"41","author":"Escorihuela","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.pnpbp.2005.04.013","article-title":"Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: correlation with the hippocampal glutamate release","volume":"29","author":"Ferrero","year":"2005","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.03.025_bib28","first-page":"17","article-title":"Evaluation of variables for the \u2018timed intravenous infusion\u2019 procedure for pentyleneterazol seizures in mice","volume":"126","author":"Fingl","year":"1960","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2009.03.025_bib29","first-page":"93","article-title":"CNS effects of convulsive therapy: significance for a theory of depressive psychosis","volume":"60","author":"Fink","year":"1972","journal-title":"Proc. Annu. Meet. Am. Psychopathol. Assoc."},{"key":"10.1016\/j.ejphar.2009.03.025_bib30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1176\/ajp.141.9.1034","article-title":"Meduna and the origins of convulsive therapy","volume":"141","author":"Fink","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.03.025_bib31","first-page":"651","article-title":"Epilepsy","volume":"32","author":"Fisher","year":"1991","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2009.03.025_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(84)90665-4","article-title":"Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat","volume":"105","author":"Foote","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02245072","article-title":"Caffeine augmentation of electroconvulsive seizures","volume":"115","author":"Francis","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0173(83)90039-5","article-title":"Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems","volume":"6","author":"Frenk","year":"1983","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2009.03.025_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0028-3908(80)90141-0","article-title":"Cetyl GABA: effect of convulsant thresholds in mice and acute toxicity","volume":"19","author":"Frey","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0773.1962.tb01696.x","article-title":"On the anticonvulsant activity of local anaesthetics","volume":"19","author":"Frey","year":"1962","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib37","first-page":"39","article-title":"Morphine-like analgesics and convulsive threshold for pentetrazole in dogs","volume":"283","author":"Frey","year":"1986","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2009.03.025_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0028-3908(91)90086-Q","article-title":"Effect of psychotropic agents on a model of absence epilepsy in rats","volume":"30","author":"Frey","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib39","series-title":"Influence of Tramadol and Reference on the Threshold of Chemically and Electrically Induced Seizures in the Mouse. Report No. F0-PH\/249","author":"Friderichs","year":"1987"},{"key":"10.1016\/j.ejphar.2009.03.025_bib40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.28.9.953","article-title":"Imipramine in absence and myoclonic\u2013astatic seizures","volume":"28","author":"Fromm","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.410230304","article-title":"Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy","volume":"23","author":"Frost","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib42","series-title":"Safety Pharmacology in Pharmaceutical Development and Approval","author":"Gad","year":"2003"},{"key":"10.1016\/j.ejphar.2009.03.025_bib43","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1592\/phco.20.19.1423.34854","article-title":"Tramadol and seizures: a surveillance study in a managed care population","volume":"20","author":"Gardner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2009.03.025_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","article-title":"Incidence of first-time idiopathic seizures in users of tramadol","volume":"20","author":"Gasse","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2009.03.025_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/mf.1998.20.5.485700","article-title":"Protective effect of clozapine against pentylenetetrazol convulsions and kindling","volume":"20","author":"George","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.2042-7158.1989.tb06395.x","article-title":"A simple intravenous infusion method in rodents for determining the potency of anticonvulsants acting through GABAergic mechanisms","volume":"41","author":"Green","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2009.03.025_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1081\/CLT-44771","article-title":"Seizures reported in association with use of dietary supplements","volume":"43","author":"Haller","year":"2005","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib49","first-page":"239","article-title":"Pentylenetetrazol seizure threshold in the rat during recovery phase from propofol and thiopentone induced anesthesia","volume":"48","author":"Hasan","year":"1997","journal-title":"Acta Anaesthesiol. Belg."},{"key":"10.1016\/j.ejphar.2009.03.025_bib50","first-page":"359","article-title":"The effect of propofol and thiopentone on pentylenetetrazol seizure threshold in the rat","volume":"11","author":"Hasan","year":"1992","journal-title":"Middle East J. Anaesthesiol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib51","first-page":"631","article-title":"[The effect of neuroleptics and neuroleptic\/analgesic combinations on the sensitivity to seizures in mice]","volume":"37","author":"Hashem","year":"1988","journal-title":"Anaesthesist"},{"key":"10.1016\/j.ejphar.2009.03.025_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14712\/18059694.2020.35","article-title":"Effect of alprazolam and ketamine on seizures induced by two different convulsants","volume":"40","author":"Herink","year":"1997","journal-title":"Acta Medica (Hradec. Kralove)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib53","first-page":"173","article-title":"Are nootropics a separate class of drugs? A differentiation in various models","volume":"9","author":"Herrmann","year":"1987","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.vascn.2008.06.001","article-title":"Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds","volume":"58","author":"Himmel","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2009.03.025_bib147","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0773.1958.tb01152.x","article-title":"A simple intravenous infusion technique for mice; method and some applications","volume":"14","author":"Hint","year":"1958","journal-title":"Acta Pharmacol. Toxicol. (Copenh)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.38.6.924","article-title":"Effect of isoflurane and enflurane on the electrocorticogram of epileptic patients","volume":"38","author":"Ito","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib56","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000090565.15739.8D","article-title":"Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia","volume":"61","author":"Jaaskelainen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/j.1875-9114.1998.tb03123.x","article-title":"The risk of seizures associated with tramadol","volume":"18","author":"Jick","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2009.03.025_bib58","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1460-9568.1996.tb01539.x","article-title":"Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding","volume":"8","author":"Johansson","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.03.025_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0149-7634(02)00010-6","article-title":"The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments","volume":"26","author":"Jung","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2009.03.025_bib60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2008-1079342","article-title":"The use of psychotropic drugs in epilepsy: what every neurologist should know","volume":"28","author":"Kanner","year":"2008","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0074-7742(08)00022-6","article-title":"Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs","volume":"83","author":"Kanner","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/089198879500800305","article-title":"Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study","volume":"8","author":"Kelsey","year":"1995","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib63","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.278.20.1661b","article-title":"Seizures reported with tramadol","volume":"278","author":"Khan","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2009.03.025_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0028-3908(73)90121-4","article-title":"Central monoamines and convulsive thresholds in mice and rats","volume":"12","author":"Kilian","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/1056-8719(95)00115-8","article-title":"Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice","volume":"35","author":"Kitano","year":"1996","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2009.03.025_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-1211(02)00068-2","article-title":"Use of epileptic animals for adverse effect testing","volume":"50","author":"Klitgaard","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00008506-199710000-00011","article-title":"Anesthetic implications of epilepsy, status epilepticus, and epilepsy surgery","volume":"9","author":"Kofke","year":"1997","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1528-1157.1987.tb03667.x","article-title":"Caffeine blocks absence seizures in the tottering mutant mouse","volume":"28","author":"Kostopoulos","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib69","first-page":"2","article-title":"CNS safety pharmacology: international guidelines and methods","volume":"8","author":"Kumar","year":"2007","journal-title":"CRIPS"},{"key":"10.1016\/j.ejphar.2009.03.025_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1528-1157.1976.tb03396.x","article-title":"Biphasic effects of imipramine in experimental models of epilepsy","volume":"17","author":"Lange","year":"1976","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0028-3908(94)90002-7","article-title":"The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole","volume":"33","author":"Lauretti","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0006-8993(86)91431-9","article-title":"Opioid receptor alterations in a genetic model of generalized epilepsy","volume":"380","author":"Lee","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ajhp\/54.6.643","article-title":"Tramadol: a new centrally acting analgesic","volume":"54","author":"Lewis","year":"1997","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.ejphar.2009.03.025_bib74","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(48)80169-1","article-title":"The use of benzedrine and dexedrine sulfate in the treatment of epilepsy","volume":"32","author":"Livingston","year":"1948","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejphar.2009.03.025_bib75","series-title":"Antiepileptic Drugs. Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-60072-2_2","article-title":"Animal models of epilepsy and epileptic seizures","author":"L\u00f6scher","year":"1999"},{"key":"10.1016\/j.ejphar.2009.03.025_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(86)90557-1","article-title":"Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy","volume":"128","author":"L\u00f6scher","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0165-6147(91)90496-F","article-title":"Responses to NMDA receptor antagonists altered by epileptogenesis","volume":"12","author":"L\u00f6scher","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2009.03.025_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(91)90041-D","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices","volume":"9","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1528-1157.1995.tb01637.x","article-title":"Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous (\u201ccontrolled release\u201d) administration in a model of generalized seizures in rats","volume":"36","author":"L\u00f6scher","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib84","first-page":"652","article-title":"Acute exposure to caffeine decreases the anticonvulsant action of ethosuximide, but not that of clonazepam, phenobarbital and valproate against pentetrazole-induced seizures in mice","volume":"58","author":"Luszczki","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2009.03.025_bib85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c. PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2009.03.025_bib86","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/0024-3205(74)90025-3","article-title":"Opiate receptor phenomenon: proconvulsant action of morphine in the mouse","volume":"15","author":"Mannino","year":"1974","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.03.025_bib87","first-page":"407","article-title":"Tramadol, a centrally acting opioid: anticonvulsant effect against maximal electroshock seizure in mice","volume":"42","author":"Manocha","year":"1998","journal-title":"Ind. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib88","first-page":"1002","article-title":"Possible mechanism of anticonvulsant effect of ketamine in mice","volume":"39","author":"Manocha","year":"2001","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2005.07.013","article-title":"On the mechanism of anticonvulsant effect of tramadol in mice","volume":"82","author":"Manocha","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2009.03.025_bib90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0014-4886(84)90145-6","article-title":"Morphine responsiveness and seizure proneness","volume":"85","author":"Mansour","year":"1984","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0163-8343(87)90025-9","article-title":"Seizures with neuroleptics and antidepressants","volume":"9","author":"Markowitz","year":"1987","journal-title":"Gen. Hosp. Psych."},{"key":"10.1016\/j.ejphar.2009.03.025_bib148","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1528-1157.1986.tb03572.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats","volume":"27","author":"Miller","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib92","first-page":"433","article-title":"Pro- and anticonvulsant effects of anesthetics (Part II)","volume":"70","author":"Modica","year":"1990","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2009.03.025_bib93","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0028-3908(85)90010-3","article-title":"Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat","volume":"24","author":"Murray","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2009.03.025_bib95","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.2042-7158.1986.tb03114.x","article-title":"Optimizing the pentetrazol infusion test for seizure threshold measurement","volume":"38","author":"Nutt","year":"1986","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0773.1993.tb01639.x","article-title":"Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice","volume":"72","author":"Ogren","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3181\/00379727-70-16891","article-title":"Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs","volume":"70","author":"Orloff","year":"1949","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2009.03.025_bib98","first-page":"135","article-title":"Allgemeine pharmakologische Untersuchungen mit Tramadol, einem stark wirkenden Analgetikum","volume":"28","author":"Osterloh","year":"1978","journal-title":"Arzneim.-Forsch. (Drug Res.)"},{"key":"10.1016\/j.ejphar.2009.03.025_bib99","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jep.2008.10.037","article-title":"Proconvulsant effect of khat (Catha edulis) in Sprague Dawley rats","volume":"121","author":"Oyungu","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib101","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1474-4422(07)70215-6","article-title":"Development of new antiepileptic drugs: challenges, incentives, and recent advances","volume":"6","author":"Perucca","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib102","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0301-0082(82)90008-9","article-title":"Neurotransmitter and neuromodulator function in the kindled seizure and state","volume":"19","author":"Peterson","year":"1982","journal-title":"Progr.Neurobiol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2009.03.025_bib104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0160-5402(85)90057-9","article-title":"A timed intravenous pentylenetetrazol infusion seizure model for quantitating the anticonvulsant effect of valproic acid in the rat","volume":"13","author":"Pollack","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ejphar.2009.03.025_bib105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1472-8206.2002.00061.x","article-title":"New perspectives in CNS safety pharmacology","volume":"16","author":"Porsolt","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bjp.0703562","article-title":"Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy","volume":"131","author":"Potschka","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib107","first-page":"160","article-title":"Tricyclic antidepressant-induced seizures and plasma drug concentration","volume":"53","author":"Preskorn","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.03.025_bib108","series-title":"Antiepileptic Drugs","first-page":"101","article-title":"Monoamines and the pathophysiology of seizure disorders","author":"Przegalinski","year":"1985"},{"key":"10.1016\/j.ejphar.2009.03.025_bib109","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/jpet.108.137273","article-title":"Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice","volume":"325","author":"Raffa","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.025_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(84)90282-6","article-title":"Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine\u2013GABA receptor\u2013ionophore complex","volume":"98","author":"Ramanjaneyulu","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib111","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-7843.2008.00276.x","article-title":"Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway","volume":"103","author":"Rehni","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib112","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/0024-3205(88)90040-9","article-title":"Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions","volume":"42","author":"Reigel","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.03.025_bib113","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","first-page":"521","article-title":"Opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.ejphar.2009.03.025_bib114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-1211(93)90044-8","article-title":"Characterization of mu opoid receptor binding during amygdala kindling in rats and effects of chronic naloxone pretreatment: an autoradiographic study","volume":"14","author":"Rocha","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.025_bib116","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1213\/01.ane.0000287675.15225.0b","article-title":"Mechanisms of morphine enhancement of spontaneous seizure activity","volume":"105","author":"Saboory","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2009.03.025_bib117","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0404.108.s180.3.x","article-title":"Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management","volume":"180","author":"Sander","year":"2003","journal-title":"Acta Neurol. Scand., Suppl."},{"key":"10.1016\/j.ejphar.2009.03.025_bib118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0100-879X2002000400010","article-title":"Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats","volume":"35","author":"Santos","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejphar.2009.03.025_bib119","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0013-4694(90)90099-6","article-title":"Kindling: basic mechanisms and clinical validity","volume":"76","author":"Sato","year":"1990","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"Suppl 7","key":"10.1016\/j.ejphar.2009.03.025_bib120","doi-asserted-by":"crossref","first-page":"S1669","DOI":"10.1093\/clinids\/11.Supplement_7.S1669","article-title":"Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system","volume":"11","author":"Scheld","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejphar.2009.03.025_bib121","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0031-3955(16)31260-3","article-title":"The diagnosis and treatment of seizures","volume":"9","author":"Scholl","year":"1962","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.ejphar.2009.03.025_bib122","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0028-3908(86)90008-0","article-title":"Effect of opiates on the parameters of seizures in rats with full amygdaloid-kindled convulsions","volume":"25","author":"Schwark","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2009.03.025_bib123","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0310057X0002800403","article-title":"Tramadol\u2014present and future","volume":"28","author":"Shipton","year":"2000","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ejphar.2009.03.025_bib124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/seiz.1999.0346","article-title":"Illicit drugs and seizures","volume":"8","author":"Smith","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2009.03.025_bib125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/15563659709043367","article-title":"Prospective multicenter evaluation of tramadol exposure","volume":"35","author":"Spiller","year":"1997","journal-title":"J. Toxicol., Clin. Toxicol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2009.03.025_bib127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00124509-199912000-00003","article-title":"Aminophylline increases seizure length during electroconvulsive therapy","volume":"15","author":"Stern","year":"1999","journal-title":"J. ECT"},{"key":"10.1016\/j.ejphar.2009.03.025_bib128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006842-194404000-00004","article-title":"The effect of mental activity on the incidence of seizures and the electroencephalographic pattern in some epileptics","volume":"6","author":"Strauss","year":"1944","journal-title":"Psychonom. Med."},{"key":"10.1016\/j.ejphar.2009.03.025_bib129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0310057X9402200620","article-title":"Propofol and seizures","volume":"22","author":"Sutherland","year":"1994","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ejphar.2009.03.025_bib130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/YCT.0b013e3181571ad0","article-title":"Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy","volume":"24","author":"Taylor","year":"2008","journal-title":"J. ECT"},{"key":"10.1016\/j.ejphar.2009.03.025_bib131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00007611-197502000-00017","article-title":"Interaction between local anesthetics and analeptic drugs","volume":"68","author":"Thompson","year":"1975","journal-title":"South. Med. J."},{"key":"10.1016\/j.ejphar.2009.03.025_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03161033","article-title":"Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System","volume":"3","author":"Thundiyil","year":"2007","journal-title":"J. Med. Toxicol."},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2009.03.025_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2002.043s2008.x","article-title":"Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations","volume":"43","author":"Torta","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2004.07.105","article-title":"Convulsant and anticonvulsant effects of bupropion in mice","volume":"499","author":"Tutka","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0091-3057(80)90237-3","article-title":"Pro- and anticonvulsant action of morphine in rats","volume":"13","author":"Urca","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2009.03.025_bib136","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.npp.1301143","article-title":"Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors","volume":"32","author":"Uzbay","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl D","key":"10.1016\/j.ejphar.2009.03.025_bib137","first-page":"65","article-title":"Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects?","volume":"24","author":"Van Luijtelaar","year":"2002","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib138","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0041-008X(81)90240-4","article-title":"Neuropharmacological effects of isomers of hexachlorocyclohexane. 1. Protection against pentylenetetrazol-induced convulsions","volume":"57","author":"Vohland","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.025_bib139","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1553-2712.1997.tb03820.x","article-title":"Lidocaine in the treatment of status epilepticus","volume":"4","author":"Walker","year":"1997","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.ejphar.2009.03.025_bib140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-7258(02)00218-8","article-title":"The role of catecholamines in seizure susceptibility: new results using genetically engineered mice","volume":"94","author":"Weinshenker","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2009.03.025_bib141","series-title":"Epilepsy. A Comprehensive Textbook","first-page":"1469","article-title":"Screening of new compounds and the role of the pharmaceutical industry","author":"White","year":"2008"},{"key":"10.1016\/j.ejphar.2009.03.025_bib142","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1528-1157.1969.tb03839.x","article-title":"Role of pharmacological factors in the evaluation of anticonvulsant drugs","volume":"10","author":"Woodbury","year":"1969","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2009.03.025_bib143","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/S0317167100031589","article-title":"The effect of tricyclic antidepressants on cortex- and amygdala-kindled seizures in the rat","volume":"18","author":"Yacobi","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2009.03.025_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2007.04.004","article-title":"Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice","volume":"11","author":"Yilmaz","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2009.03.025_bib145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0165-0270(86)90023-3","article-title":"A simple method for quantitative electroencephalographic assessment of drugs with convulsant and anticonvulsant properties","volume":"18","author":"Zaczek","year":"1986","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2009.03.025_bib146","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neulet.2004.10.009","article-title":"The effect of fluoxetine in a model of chemically induced seizures\u2014behavioral and immunocytochemical study","volume":"373","author":"Zienowicz","year":"2005","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T13:01:00Z","timestamp":1739019660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":148,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0014299909002441"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.03.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}